AngioDynamics Inc. expects to close on its purchase of certain assets of Diomed Holdings, in the United State and the United Kingdom, on or about June 16.
The U.S. Bankruptcy Court in Boston gave its approval for AngioDynamics' deal for U. S. assets of Diomed and its wholly-owned subsidiary, Diomed Inc. on June 3. Diomed, which is based in Andover, Mass., filed for Chapter 11 bankruptcy protection in March.
AngioDynamics (Nasdaq: ANGO), a medical device maker based in Queensbury, had agreed in April to pay $8 million in cash for the U.S. assets, and $3 million in cash for certain assets of Diomed Ltd in the United Kingdom.
full article >> http://albany.bizjournals.com/albany/stories/2008/06/02/daily46.html?ana=yfcpc
Monday, June 9, 2008
AngioDynamics' purchase of certain Diomed Holdings set to close this month
Analysts mixed on patent victory's impact on Vnus
Analysts mixed on impact of Vnus patent victory; Piper Jaffray downgrades to "Neutral"
NEW YORK (AP) -- While medical device maker Vnus Medical Technologies Inc. claimed a major patent litigation victory Tuesday against two rivals, analysts are mixed over the victory's effect on the company's future performance.
Under a settlement announced Tuesday with AngioDynamics Inc. and Vascular Solutions Inc, the two companies will pay Vnus a total of $9.9 million in back royalties. The two companies were also granted a license to use Vnus products in the treatment of varicose veins.
While boosting his price target $1 to $21, Piper Jaffray analyst Thomas J. Gunderson Sr. cut his rating on Vnus shares to "Neutral" from "Buy," noting the stock has had a 46 percent run-up year-to date. He also expects revenue growth to slow.
MedCentric blog back up and running!
Dear Bloggers,
With a reinforced staff, the MedCentric blog is back online! As always, your suggestions for blog topics are welcomed and encouraged! As a reminder, you can use the links to the right to sign up for the MedCentric Blog via email or RSS feed - a great way to get the most up-to-date news!
- The MedCentric Team
Subscribe to:
Posts (Atom)
